ADVFN Logo
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

RVLP RVL Pharmaceuticals PLC

0.0282
0.00 (0.00%)
23 2월(2) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
RVL Pharmaceuticals PLC RVLP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 0.0282 09:00:00
개장가 저가 고가 종가 전일 종가
0.0282 0.0282
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
18/01/202406:05EDGAR2Form 8-K - Current report
21/12/202306:15EDGAR2Form 8-K - Current report
27/11/202320:50GLOBERVL Completes Financial Restructuring
16/11/202323:11EDGAR2Form DEF 14A - Other definitive proxy statements
02/11/202305:27EDGAR2Form SC 13D/A - General statement of acquisition of..
24/10/202305:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202306:00EDGAR2Form 8-K - Current report
21/10/202304:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202305:00EDGAR2Form 144 - Report of proposed sale of securities
14/10/202306:28EDGAR2Form SC 13D/A - General statement of acquisition of..
14/10/202305:15EDGAR2Form 8-K - Current report
12/10/202319:50GLOBERVL Pharmaceuticals plc Announces Prepackaged Reorganization..
30/09/202305:05EDGAR2Form 8-K - Current report
23/09/202305:05EDGAR2Form 8-K - Current report
06/09/202305:18EDGAR2Form DEF 14A - Other definitive proxy statements
06/09/202305:06EDGAR2Form 8-K - Current report
05/09/202320:45EDGAR2Form SC 13D - General statement of acquisition of beneficial..
01/09/202303:23EDGAR2Form D - Notice of Exempt Offering of Securities
26/08/202306:21EDGAR2Form PRE 14A - Other preliminary proxy statements
26/08/202305:17EDGAR2Form 8-K - Current report
24/08/202306:30EDGAR2Form S-3 - Registration statement under Securities Act of..
24/08/202305:05GLOBERVL Pharmaceuticals plc to Present at the H.C. Wainwright..
19/08/202305:06EDGAR2Form 8-K - Current report
18/08/202306:06EDGAR2Form SC 13D/A - General statement of acquisition of..
18/08/202306:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/08/202305:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/08/202321:00GLOBERVL Pharmaceuticals plc Announces $5 Million Registered..
15/08/202306:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/08/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/08/202320:51EDGAR2Form 8-K - Current report
14/08/202319:50GLOBERVL Pharmaceuticals plc Reports Second Quarter 2023..
03/08/202306:00EDGAR2Form 8-K - Current report
02/08/202321:30GLOBERVL Pharmaceuticals plc to Discuss Second Quarter 2023..
12/07/202310:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202310:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/07/202319:50GLOBERVL Pharmaceuticals plc Provides Business Update
16/06/202305:15GLOBERVL Pharmaceuticals plc Announces Result of Proposal to..
11/05/202319:50GLOBERVL Pharmaceuticals plc Reports First Quarter 2023 Financial..
04/05/202319:50GLOBERVL Pharmaceuticals plc to Discuss First Quarter 2023..
04/04/202302:00GLOBERVL Pharmaceuticals Announces that Upneeq® Wins “Best Eye..
20/03/202319:50GLOBERVL Pharmaceuticals plc Reports Fourth Quarter and Full Year..
15/03/202319:50GLOBERVL Pharmaceuticals plc to Discuss Fourth Quarter and Full..

최근 히스토리

Delayed Upgrade Clock

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

도움 및 지원받기: kr-support@advfn.com